EE836 Cost-Effectiveness of Zolbetuximab Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Adenocarcinoma in Taiwan
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.1116
https://www.valueinhealthjournal.com/article/S1098-3015(24)03979-2/fulltext
Title :
EE836 Cost-Effectiveness of Zolbetuximab Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Adenocarcinoma in Taiwan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03979-2&doi=10.1016/j.jval.2024.10.1116
First page :
Section Title :
Open access? :
No
Section Order :
10602